When we compared the excess mortality between CPP and non-CPP referred patients, an overall trend of lower excess mortality was observed among CPP-referred patients compared to non-CPP referred patients (EHR 3years = 0.91 (95% CI: 0.79;1.04)) (Tables 4 and 5 ), with statistically significantly lower excess mortality only among lung cancer patients (EHR 3years = 0.77 (95% CI: 0.62;0.65)) (Tables 4 and 5 ).
← all excerpts
Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care.
1
—
—